Sorry I mixed up the name of two drugs in my posts.
"Are you asking whether Hepsera still has a role to play in patients who become resistant to Viread? The answer is No, Hepsera is unlikely to help such patients and it would be bad medicine to even try if there are other approved HBV drugs to which such patients are treatment-naïve. Regards, Dew"
Yes that is what I was asking and I thought this would be the answer, I just wanted to be sure.
Market Data 
Markets 
AI
